Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
CC transcript
|
|
ALBANY MOLECULAR RESEARCH INC (AMRI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/23/2016 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits|
Docs:
|
"Consent of EY S.p.A",
"Consent of EY S.p.A",
"Audited consolidated financial statements of Euticals as of December 31, 2015 and 2014 and for the three years ended December 31, 2015, 2014 and 2013",
"Audited consolidated financial statements of Euticals as of December 31, 2015 and 2014 and for the three years ended December 31, 2015, 2014 and 2013",
"Unaudited pro forma condensed combined financial statements and related notes thereto of Albany Molecular Research, Inc. at June 30, 2016 and for the six months ended June 30, 2016 and the year ended December 31, 2015",
"Unaudited pro forma condensed combined financial statements and related notes thereto of Albany Molecular Research, Inc. at June 30, 2016 and for the six months ended June 30, 2016 and the year ended December 31, 2015" |
|
| 02/02/2011 |
8-K/A
| Other Events |
| 03/17/2003 |
8-K/A
| Acquisition or disposition of assets, Financial statements and exhibits |
| 04/10/2001 |
8-K/A
| Acquisition or disposition of assets, Financial statements and exhibits |
| 03/06/2000 |
8-K/A
| Acquisition or disposition of assets, Financial statements and exhibits |
| 01/05/2000 |
8-K/A
| Acquisition or disposition of assets, Financial statements and exhibits |
|
|